Protein-loaded poly(DL-lactide-co-glycolide) microparticles for oral administration: Formulation, structural and release characteristics

Journal of Controlled Release

Volumn 43, Issue 1, 1997, Pages 89-102

  Rafati, H ^a   Coombes, A G A ^a   Adler, J ^a   Holland, J ^a   Davis, S S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Oral delivery; Poly(lactide co glycolide); Protein loaded microparticles

Indexed keywords

BOVINE SERUM ALBUMIN; MICROSPHERE; POLYGLACTIN; RESOMER RG755; UNCLASSIFIED DRUG;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; EMULSION; EVAPORATION; MICROENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TECHNIQUE;

EID: 0031060393     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01475-7     Document Type: Article

References (31)

1. R.G. Tice and D.R. Cowsar, Biodegradable controlled-release parenteral systems. Pharm. Tech. 8 (1984) 26-35.
2. R. Langer, New methods of drug delivery. Science 249 (1990) 1527-1533.
3. D.H. Lewis, Controlled release of bioactive agents from lactide/glycolide polymers. In: M. Chassin and R. Langer (Eds.), Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, New York, 1990, pp. 1-41.
4. W. Morris, M.C. Steinhoff and RK. Russell, Potential of polymer microencapsulation technology for vaccine innovation. Vaccine 12 (1994) 5-11.
5. D.T. O'Hagan, Oral delivery of vaccines. Clin. Pharmacokinet. 22 (1992) 1-10.
6. D.T. O'Hagan, H. Jeffery and S.S. Davis, Long term antibody response in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. Vaccine 11 (1993) 965-969.
7. J.H. Eldridge, C.J. Hammond, J.A. Meulbroek, J.K. Staas, R.M. Gilley and T.R. Tice, Controlled vaccine release in the gut-associated lymphoid tissues. 1. Orally administered biodegradable microparticles target the Peyer's patches. J. Control. Release 11 (1990) 205-214.
8. J. P. McGee, J. Mestecky, M.T. Dertzbaugh, J.H. Eldridge, M. Hirasawa and H. Kiyono, The mucosal immune systems: from fundamental concepts to vaccine development. Vaccine 10 (1992) 75-87.
9. D.T. O'Hagan, J.P. McGee, M. Lindblad and J. Holmgren, Cholera toxin B subunit (CTB) entrapped in microparticles shows comparable immunogenicity to CTB mixed with whole cholera toxin following oral immunization. Int. J. Pharm. 119 (1995) 251-255.
10. T. Uchida and S.H. Goto, Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study. Biol. Pharm. Bull. 17 (1994) 1272-1276.
11. P.U. Jani, A.T. Florence and D.E. McCarthy, Further histological evidence of the gasterointestinal absorption of polystyrene nanospheres in rat. Int. J. Pharm. 84 (1992) 245-252.
12. P.G. Jenkins, K.A. Howard, N.W. Blackball, N.W. Thomas, S.S. Davis and D.T. O'Hagan, Microparticulate absorption from the rat intestine. J. Control. Release 29 (1994) 339-350.
13. R. Jalil and J.R. Nixon, Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J. Microencapsul. 7 (1990) 297-325.
14. R. Arshady, Preparation of biodegradable microparticles and microcapsules. 2. Polylactide and related polyesters. J. Control. Release 17 (1991) 1-22.
15. Y. Ogawa, M. Yamomoto, H. Okada, T.T. Yashiko and T. Shimamoto, A new technique to efficiently entrap Leuprolide acetate into microcapsules of copoly lactic/glycolic acid. Chem. Pharm. Bull. 36 (1988) 1095-1103.
16. M.N. Vrancken and D.A. Claeys, U.S. Patent 3526906, 1970.
17. H. Jeffery, S.S. Davis and D.T. O'Hagan, The preparation and characterisation of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in oil-in water) emulsion solvent evaporation technique. Pharm. Res. 10 (1993) 362-368.
18. S. Cohen, T. Yoshioka, M. Lucarelli, H.L. Hwang and R. Langer, Controlled delivery systems for protein based on poly(lactic/glycolic acid) microparticles. Pharm. Res. 8 (1991) 713-720.
19. M.J.B. Prieto, F. Delie, E. Fattal, A. Tartar, F. Puisieux, A. Gulik and P. Couvreur, Characterisation of V3BRU peptide-loaded small PLGA microparticles prepared by a (W1/O)W2 emulsion solvent evaporation method. Int. J. Pharm. 111 (1994) 137-145.
20. C. Yan, J.H. Resau, J. Heweston, M. West, W.L. Rill and M. Kende, Characterisation and morphological analysis of protein loaded poly(lactide-co-glycolide) microparticles prepared by water-in-oil-in-water emulsion technique. J. Control. Release 32 (1994) 231-241.
21. M.S. Hora, R.K. Rana, J.H. Nunberg, T.R. Tice and R.M. Gilley, Release of human serum albumin from poly(lactide-co-glycolide) microparticles. Pharm. Res. 7 (1990) 1190-1194.
22. B. Alberts, B. Dennis, L. Julian, M. Raff, K. Roberts and J.D. Watson, Molecular Biology of Cells, Garland Publishing, New York.
23. N. Nihant, C. Schugens, C. Grandfils, R. Jerome and P. Teyssie, Polylactide microparticles prepared by double emulsion/evaporation technique. I. Effect of primary emulsion stability. Pharm. Res. 11 (1994) 1479-1484.
24. G. Crotts and T.G. Park, Preparation of porous and nonporous biodegradable polymeric hollow microspheres. J. Control. Release 35 (1995) 91-105.
25. H. K. Sah, R. Toddywala and Y.W. Chien, The influence of biodegradable microcapsules formulation on the controlled release of a protein. J. Control. Release 30 (1994) 201-211.
26. H.T. Wang, E. Schmitt, D.R. Flanagan and R.J. Linhardt, Influence of formulation methods on the in vivo controlled release of protein from poly(ester) microparticles. J. Control. Release 17 (1991) 23-32.
27. A.G.A. Coombes, E.C. Lavelle, P.G. Jenkins and S.S. Davis, Surface dose polymeric microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen. Vaccine (1996) in press.
28. L. Tang and J.W Eaton, Mechanism of acute inflammatory response to biomaterials. Cells Mater. 4 (1994) 429-436.
29. R. Arshady, Microparticles and microcapsules. A survey of manufacturing techniques. Part III. Solvent evaporation. Polym. Eng. Sci. 30 (1990) 915-921.
30. R. Bodmeier and J.W. McGinity, Solvent selection in the preparation of poly(DL-lactide) microparticles prepared by the solvent evaporation method. Int. J. Pharm. 43 (1988) 179-186.
31. P.D. Scholes, A.G.A. Coombes, L. Illum, S.S. Davis and M.C. Davies, The preparation of sub-150 nm poly(lactide-co-glycolide) microparticles for site specific drug delivery. J. Control. Release 25 (1993) 145-153.